Press Release

Kalytera Therapeutics and Ramot at Tel Aviv University to Study Bone Healing Properties of Kalytera Drug Candidates; Companies to Pioneer Synthetic CBD Pharma Research

By | Press Release
Kalytera Therapeutics, Inc., a pharmaceutical company developing a portfolio of non-psychoactive cannabinoid (“CBD”) and synthetic CBD medicines that address the unmet needs of large patient populations, and Ramot at Tel Aviv University (“Ramot”) (“TAU”), today announced they have signed a...
Read More